Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort

被引：35

作者：

Rimsza, Lisa M. ^{[1
]}

Li, Hongli ^{[2
]}

Braziel, Rita M. ^{[3
]}

Spier, Catherine M. ^{[4
]}

Persky, Daniel O. ^{[5
]}

Dunlap, Jennifer ^{[6
]}

LeBlanc, Michael ^{[2
]}

Bartlett, Nancy ^{[6
]}

Leonard, John P. ^{[7
,8
]}

Smith, Sonali M. ^{[9
]}

Press, Oliver W. ^{[2
]}

Friedberg, Jonathan W. ^{[10
]}

机构：

[1] Mayo Clin, Dept Lab Med & Pathol, Scottsdale, AZ 85255 USA

[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

[3] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR USA

[4] Univ Arizona, Dept Pathol, Tucson, AZ USA

[5] Univ Arizona, Ctr Canc, Tucson, AZ USA

[6] Washington Univ, Siteman Canc Ctr, St Louis, MO USA

[7] Weill Cornell Med, New York, NY USA

[8] New York Presbyterian Hosp, New York, NY USA

[9] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA

[10] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA

来源：

HAEMATOLOGICA | 2018年 / 103卷 / 04期

基金：

美国国家卫生研究院;

关键词：

CHOP PLUS RITUXIMAB; 1ST-LINE TREATMENT; TRIAL; PATHOLOGY; INDOLENT; RISK;

D O I：

10.3324/haematol.2017.175059

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E151 / E153

页数：3

共 16 条

[1] Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study [J].

Casulo, Carla ;

Byrtek, Michelle ;

Dawson, Keith L. ;

Zhou, Xiaolei ;

Farber, Charles M. ;

Flowers, Christopher R. ;

Hainsworth, John D. ;

Maurer, Matthew J. ;

Cerhan, James R. ;

Link, Brian K. ;

Zelenetz, Andrew D. ;

Friedberg, Jonathan W. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (23) :2516-U55

[2] Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study [J].

Flinn, Ian W. ;

van der Jagt, Richard ;

Kahl, Brad S. ;

Wood, Peter ;

Hawkins, Tim E. ;

MacDonald, David ;

Hertzberg, Mark ;

Kwan, Yiu-Lam ;

Simpson, David ;

Craig, Michael ;

Kolibaba, Kathryn ;

Issa, Samar ;

Clementi, Regina ;

Hallman, Doreen M. ;

Munteanu, Mihaela ;

Chen, Ling ;

Burke, John M. .

BLOOD, 2014, 123 (19) :2944-2952

[3] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].

KAPLAN, EL ;

MEIER, P .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481

[4] Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL [J].

Koch, K. ;

Hoster, E. ;

Ziepert, M. ;

Unterhalt, M. ;

Ott, G. ;

Rosenwald, A. ;

Hansmann, M. L. ;

Bernd, W. ;

Stein, H. ;

Poeschel, V. ;

Dreyling, M. ;

Truemper, L. ;

Loeffler, M. ;

Schmitz, N. ;

Hiddemann, W. ;

Pfreundschuh, M. ;

Klapper, W. .

ANNALS OF ONCOLOGY, 2016, 27 (07) :1323-1329

[5] Comparison of Referring and Final Pathology for Patients With Non-Hodgkin's Lymphoma in the National Comprehensive Cancer Network [J].

LaCasce, Ann S. ;

Kho, Michelle E. ;

Friedberg, Jonathan W. ;

Niland, Joyce C. ;

Abel, Gregory A. ;

Rodriguez, Maria Alma ;

Czuczman, Myron S. ;

Millenson, Michael M. ;

Zelenetz, Andrew D. ;

Weeks, Jane C. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (31) :5107-5112

[6]

Mann R B, 1983, Hematol Oncol, V1, P187

[7] MORPHOLOGICAL SUBCLASSIFICATION OF FOLLICULAR LYMPHOMA - VARIABILITY OF DIAGNOSES AMONG HEMATOPATHOLOGISTS, A COLLABORATIVE STUDY BETWEEN THE REPOSITORY CENTER AND PATHOLOGY PANEL FOR LYMPHOMA CLINICAL-STUDIES [J].

METTER, GE ;

NATHWANI, BN ;

BURKE, JS ;

WINBERG, CD ;

MANN, RB ;

BARCOS, M ;

KJELDSBERG, CR ;

WHITCOMB, CC ;

DIXON, DO ;

MILLER, TP ;

JONES, SE .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (01) :25-38

[8] Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma:: 2 types of follicular lymphoma grade 3 [J].

Ott, G ;

Katzenberger, T ;

Lohr, A ;

Kindelberger, S ;

Rüdiger, T ;

Wilhelm, M ;

Kalla, J ;

Rosenwald, A ;

Müller, JG ;

Ott, MM ;

Müller-Hermelink, HK .

BLOOD, 2002, 99 (10) :3806-3812

[9] Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry [J].

Pastore, Alessandro ;

Jurinovic, Vindi ;

Kridel, Robert ;

Hoster, Eva ;

Staiger, Annette M. ;

Szczepanowski, Monika ;

Pott, Christiane ;

Kopp, Nadja ;

Murakami, Mark ;

Horn, Heike ;

Leich, Ellen ;

Moccia, Alden A. ;

Mottok, Anja ;

Sunkavalli, Ashwini ;

Van Hummelen, Paul ;

Ducar, Matthew ;

Ennishi, Daisuke ;

Shulha, Hennady P. ;

Hother, Christoffer ;

Connors, Joseph M. ;

Sehn, Laurie H. ;

Dreyling, Martin ;

Neuberg, Donna ;

Moeller, Peter ;

Feller, Alfred C. ;

Hansmann, Martin L. ;

Stein, Harald ;

Rosenwald, Andreas ;

Ott, German ;

Klapper, Wolfram ;

Unterhalt, Michael ;

Hiddemann, Wolfgang ;

Gascoyne, Randy D. ;

Weinstock, David M. ;

Weigert, Oliver .

LANCET ONCOLOGY, 2015, 16 (09) :1111-1122

[10] A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP-Rituximab versus CHOP+131Iodine-Tositumomab [J].

Press, Oliver W. ;

Unger, Joseph M. ;

Rimsza, Lisa M. ;

Friedberg, Jonathan W. ;

LeBlanc, Michael ;

Czuczman, Myron S. ;

Kaminski, Mark ;

Braziel, Rita M. ;

Spier, Catherine ;

Gopal, Ajay K. ;

Maloney, David G. ;

Cheson, Bruce D. ;

Dakhil, Shaker R. ;

Miller, Thomas P. ;

Fisher, Richard I. .

CLINICAL CANCER RESEARCH, 2013, 19 (23) :6624-6632

← 1 2 →